According to a new report North America Biophotonics Market, published by KBV Research, the North America Biophotonics Market is expected to register a CAGR of 10.6% during the forecast period.
The Medical Diagnostics market dominated the North America Biophotonics Market in 2015, growing at a CAGR of 8.4% during the forecast period. The Tests & Components market is expected attain a market growth of 15.3% CAGR during 2016-2022. The Medical Therapeutics market is anticipated to grow at 13.9% during forecast period.
The See-Through Imaging market dominated the North America Biophotonics Market in 2015 growing at a CAGR of 9.6% during the forecast period. The Microscopy market is expected to attain a market size of $4,665.6 million by 2022. However, Inside Imaging market is expected to grow at CAGR of 11% during 2016-2022.
The U. S market dominated the North America Biophotonics Market in 2015, growing at a CAGR of 9.9% during the forecast period. However, Canada market is expected to grow at CAGR of 13.1% during 2016-2022.
The report has exhaustive quantitative insights providing a clear picture of the market potential in various segments across the countries in the region. The key influencing factors of the North America Biophotonics have been discussed in the report along with the elaborated company profiles of Oxford Instruments, Thermo Fisher Scientific, Lumenis Ltd, Carl Zeiss AG, Olympus Corporation, Hamamatsu Photonics K.K., Becton, Dickinson and Company, Perkinelmer, Inc., and Zecotek Photonics, Inc.
Full report: https://www.kbvresearch.com/north-america-biophotonics-market/
Related Reports:
Unique Offerings 
